PHIL revenues, a closer look In the last PR we

PHIL revenues, a closer look

In the last PR we read
"... We plan to focus first on growing several specialty medicinal plants and fruits, aiming to meet orders of approximately $45 million from prospective customers in Asia. In addition, we also raise premium organic poultry and other livestock to generate imminent cash flows and develop a model farming program without antibiotics and chemicals that can be replicated and licensed to farmers worldwide..."

The first part of that shows us orders of prospective customers. This shows us that the orders and customers are already there, an important fact. Medicinal plants and fruits for Asian holistic medicine is a huge industry. It would be interesting to discover why Asia would care to buy these products from Florida...
In the second part:
"...In addition, we also raise premium organic poultry and other livestock to generate imminent cash flows..."
we see another very important part - generating cash flow means no need to seek more funding or sell shares. It's all about the revenues and cash flow when you consider future growth. Starting to look like a company interested in upgrading to a higher market?

Finally:
"...develop a model farming program without antibiotics and chemicals that can be replicated and licensed to farmers worldwide..."
without antibiotics and chemicals is a game changer! Less costs for the production means a better profit margin, and also a competetive price. Win/win for everybody.

prof